4.1 Article

Low-dose Lithium Treatment for Agitation and Psychosis in Alzheimer Disease and Frontotemporal Dementia: A Case Series

Journal

ALZHEIMER DISEASE & ASSOCIATED DISORDERS
Volume 31, Issue 1, Pages 73-75

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/WAD.0000000000000161

Keywords

lithium; Alzheimer disease; frontotemporal dementia; agitation; psychosis

Funding

  1. National Institute of Aging [R01AG047146]
  2. NIH
  3. Lundbeck
  4. Astellas
  5. AbbVie
  6. Intracellular Therapeutics
  7. Avanir
  8. Merck
  9. AstraZeneca
  10. National Institute on Aging
  11. NIH [1UL1 RR024156-01, PO412196-G]
  12. Parkinson Disease Foundation
  13. Huntington's Disease Society of America
  14. CHDI
  15. Michael J Fox foundation
  16. TEVA
  17. Vaccinex
  18. NIH/NINDS [R00NS060766, R01NS076837]
  19. Irving Institute of Columbia University
  20. [U01NS052592]

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available